135 related articles for article (PubMed ID: 11778968)
1. Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells.
Krüger WH; Jung R; Detlefsen B; Mumme S; Badbaran A; Brandner J; Renges H; Kröger N; Zander AR
Med Oncol; 2001; 18(1):33-8. PubMed ID: 11778968
[TBL] [Abstract][Full Text] [Related]
2. Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer.
Ballestrero A; Garuti A; Bertolotto M; Rocco I; Boy D; Nencioni A; Ottonello L; Patrone F
Br J Cancer; 2005 May; 92(10):1948-52. PubMed ID: 15841077
[TBL] [Abstract][Full Text] [Related]
3. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
[TBL] [Abstract][Full Text] [Related]
4. CK20 gene expression: technical limits for the detection of circulating tumor cells.
Champelovier P; Mongelard F; Seigneurin D
Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
[TBL] [Abstract][Full Text] [Related]
5. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes.
Jung R; Petersen K; Krüger W; Wolf M; Wagener C; Zander A; Neumaier M
Br J Cancer; 1999 Nov; 81(5):870-3. PubMed ID: 10555760
[TBL] [Abstract][Full Text] [Related]
6. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
[TBL] [Abstract][Full Text] [Related]
7. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype.
Núñez-Villar MJ; Martínez-Arribas F; Pollán M; Lucas AR; Sánchez J; Tejerina A; Schneider J
Breast Cancer Res; 2003; 5(3):R65-70. PubMed ID: 12793902
[TBL] [Abstract][Full Text] [Related]
8. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung.
Chausovsky G; Luchansky M; Figer A; Shapira J; Gottfried M; Novis B; Bogelman G; Zemer R; Zimlichman S; Klein A
Cancer; 1999 Dec; 86(11):2398-405. PubMed ID: 10590383
[TBL] [Abstract][Full Text] [Related]
10. Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells.
Raynor M; Stephenson SA; Walsh DC; Pittman KB; Dobrovic A
BMC Cancer; 2002 May; 2():14. PubMed ID: 12031094
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
12. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
13. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro.
Jung R; Krüger W; Hosch S; Holweg M; Kröger N; Gutensohn K; Wagener C; Neumaier M; Zander AR
Br J Cancer; 1998 Nov; 78(9):1194-8. PubMed ID: 9820179
[TBL] [Abstract][Full Text] [Related]
14. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.
Silva AL; Tomé MJ; Correia AE; Passos-Coelho JL
Ann Oncol; 2002 Mar; 13(3):422-9. PubMed ID: 11996474
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions.
Passebosc-Faure K; Li G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6862-7. PubMed ID: 16203775
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
[TBL] [Abstract][Full Text] [Related]
17. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction.
Weber T; Amann K; Weckauf H; Lacroix J; Weitz J; Schönfuss T; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
World J Surg; 2002 Feb; 26(2):148-52. PubMed ID: 11865340
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated secretoglobin expression in human lung cancers.
Sjödin A; Guo D; Sørhaug S; Bjermer L; Henriksson R; Hedman H
Lung Cancer; 2003 Jul; 41(1):49-56. PubMed ID: 12826312
[TBL] [Abstract][Full Text] [Related]
20. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
